338 related articles for article (PubMed ID: 34358447)
1. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.
Cao Z; Budinich KA; Huang H; Ren D; Lu B; Zhang Z; Chen Q; Zhou Y; Huang YH; Alikarami F; Kingsley MC; Lenard AK; Wakabayashi A; Khandros E; Bailis W; Qi J; Carroll MP; Blobel GA; Faryabi RB; Bernt KM; Berger SL; Shi J
Mol Cell; 2021 Sep; 81(17):3604-3622.e10. PubMed ID: 34358447
[TBL] [Abstract][Full Text] [Related]
2. Exploiting a key transcriptional dependency: ZMYND8 and IRF8 in AML.
Taylor SJ; Sundaravel S; Steidl U
Mol Cell; 2021 Sep; 81(17):3445-3446. PubMed ID: 34478652
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.
Rathert P; Roth M; Neumann T; Muerdter F; Roe JS; Muhar M; Deswal S; Cerny-Reiterer S; Peter B; Jude J; Hoffmann T; Boryń ŁM; Axelsson E; Schweifer N; Tontsch-Grunt U; Dow LE; Gianni D; Pearson M; Valent P; Stark A; Kraut N; Vakoc CR; Zuber J
Nature; 2015 Sep; 525(7570):543-547. PubMed ID: 26367798
[TBL] [Abstract][Full Text] [Related]
4. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
[TBL] [Abstract][Full Text] [Related]
5. Mediator kinase inhibition further activates super-enhancer-associated genes in AML.
Pelish HE; Liau BB; Nitulescu II; Tangpeerachaikul A; Poss ZC; Da Silva DH; Caruso BT; Arefolov A; Fadeyi O; Christie AL; Du K; Banka D; Schneider EV; Jestel A; Zou G; Si C; Ebmeier CC; Bronson RT; Krivtsov AV; Myers AG; Kohl NE; Kung AL; Armstrong SA; Lemieux ME; Taatjes DJ; Shair MD
Nature; 2015 Oct; 526(7572):273-276. PubMed ID: 26416749
[TBL] [Abstract][Full Text] [Related]
6. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.
Delgado-Benito V; Rosen DB; Wang Q; Gazumyan A; Pai JA; Oliveira TY; Sundaravinayagam D; Zhang W; Andreani M; Keller L; Kieffer-Kwon KR; Pękowska A; Jung S; Driesner M; Subbotin RI; Casellas R; Chait BT; Nussenzweig MC; Di Virgilio M
Mol Cell; 2018 Nov; 72(4):636-649.e8. PubMed ID: 30293785
[TBL] [Abstract][Full Text] [Related]
7. Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia.
Pingul BY; Huang H; Chen Q; Alikarami F; Zhang Z; Qi J; Bernt KM; Berger SL; Cao Z; Shi J
iScience; 2022 Oct; 25(10):105139. PubMed ID: 36193052
[TBL] [Abstract][Full Text] [Related]
8. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia.
Harada T; Heshmati Y; Kalfon J; Perez MW; Xavier Ferrucio J; Ewers J; Hubbell Engler B; Kossenkov A; Ellegast JM; Yi JS; Bowker A; Zhu Q; Eagle K; Liu T; Kai Y; Dempster JM; Kugener G; Wickramasinghe J; Herbert ZT; Li CH; Vrabič Koren J; Weinstock DM; Paralkar VR; Nabet B; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
Genes Dev; 2022 Mar; 36(5-6):368-389. PubMed ID: 35301220
[TBL] [Abstract][Full Text] [Related]
9. Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.
Zhuang H; Li F; Xu Y; Pei R; Chen D; Liu X; Li S; Ye P; Yuan J; Lian J; Lu Y
Ann Hematol; 2023 May; 102(5):1063-1072. PubMed ID: 36959484
[TBL] [Abstract][Full Text] [Related]
10. The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.
Roe JS; Vakoc CR
Cold Spring Harb Symp Quant Biol; 2016; 81():61-66. PubMed ID: 28174254
[TBL] [Abstract][Full Text] [Related]
11. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
[TBL] [Abstract][Full Text] [Related]
12. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.
Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR
Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481
[TBL] [Abstract][Full Text] [Related]
13. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation.
Basu M; Khan MW; Chakrabarti P; Das C
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):450-459. PubMed ID: 28232094
[TBL] [Abstract][Full Text] [Related]
14. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
15. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.
Sharma A; Yun H; Jyotsana N; Chaturvedi A; Schwarzer A; Yung E; Lai CK; Kuchenbauer F; Argiropoulos B; Görlich K; Ganser A; Humphries RK; Heuser M
Leukemia; 2015 Jan; 29(1):157-68. PubMed ID: 24957708
[TBL] [Abstract][Full Text] [Related]
16. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
17. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
Riedel SS; Lu C; Xie HM; Nestler K; Vermunt MW; Lenard A; Bennett L; Speck NA; Hanamura I; Lessard JA; Blobel GA; Garcia BA; Bernt KM
Mol Cell; 2021 Jun; 81(11):2332-2348.e9. PubMed ID: 33974912
[TBL] [Abstract][Full Text] [Related]
18. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
[TBL] [Abstract][Full Text] [Related]
19. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
[TBL] [Abstract][Full Text] [Related]
20. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]